Eosinophilic hepatitis after ingestion of choline magnesium trisalicylate.
Article Details
- CitationCopy to clipboard
Nadkarni MM, Peller CA, Retig J
Eosinophilic hepatitis after ingestion of choline magnesium trisalicylate.
Am J Gastroenterol. 1992 Jan;87(1):151-3.
- PubMed ID
- 1728115 [ View in PubMed]
- Abstract
Choline magnesium trisalicylate is a non-acetylated salicylate used widely as a nonsteroidal anti-inflammatory drug. Although mild transient hepatotoxicity associated with aspirin and other salicylates has been well documented, most commonly with high-dose treatment for rheumatologic disorders 112), we report a case of severe hypersensitivity hepatitis with striking tissue and peripheral eosinophilia after ingestion of choline magnesium trisalicylate.
DrugBank Data that Cites this Article
- Drugs